Stockhead TV
Check out the latest Animal Health news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
PharmAust files for patent on lead drug monepantel to fight viral diseases
Health & Biotech
PharmAust flags good news on key stability test for Monepantel treatment
Health & Biotech
Apiam expands equine footprint and boosts Qld growth network with new acquisition, shares climb
Health & Biotech
PharmAust achieves successful Phase II trials on monepantel for canine cancer, shares jump
Health & Biotech
Apiam delivers major boost for Australia’s $5bn pork industry with Data Pig technology platform
Health & Biotech
Executive insights: How Apiam is capitalising on the major opportunity in ‘greenfield’ vet clinics
Health & Biotech
Apiam expands dominant footprint in regional markets with major Queensland acquisition
Health & Biotech
Creso Pharma expands into Eastern Europe with animal product launch in Poland
Health & Biotech
Creso Pharma launches hemp-based product for swine, enters the lucrative livestock market
Health & Biotech
The federal government just prioritised vets on its skilled migrant list – here’s why Apiam is set to be a major beneficiary
Health & Biotech
PharmAust calls on experienced exec in push to commercialise its drug for canine cancer
Health & Biotech
Apiam gains traction with analysts, institutional investors and strategic partners as regional growth plans accelerate
News
There’s never been a more exciting time to be a pet care stock; and the ASX cohort just grew further
Health & Biotech
PharmAust passes critical milestone in Phase II study of Monepantel, sets eyes on Phase III
Health & Biotech
Big investors pile in to Apiam’s $6m funding round as its regional growth strategy accelerates
Health & Biotech
Apiam shares are up more than 30pc in 2021, as corporate investors back its aggressive growth strategy
Health & Biotech
How Apiam is using technology to revolutionise regional vet care
Health & Biotech
Creso Pharma makes plans to enter US market with new partnership
Health & Biotech
Higher profits and more dividends; Apiam’s half-year results reflect a company going from strength to strength
Health & Biotech
Apiam pounces on a generational market opportunity amid booming growth in regional Australia
Health & Biotech
Your ultimate guide to ASX pet stocks
Health & Biotech
Creso Pharma experiencing strong demand for pet-health cannabis products
Health & Biotech
How a leading Apiam vet clinic converted the COVID-19 crisis into a 20pc boost in revenues
Health & Biotech
Creso Pharma picking up steam with more orders for hemp oil pet products
Health & Biotech
Apiam snaps up key vet acquisition to capitalise on post-Covid tailwinds
Health & Biotech
For Apiam, being an employer of choice is crucial to its competitive advantage
Health & Biotech
Apiam gives Aussie farmers a boost with new piglet survival treatment
Health & Biotech
Apiam shares rally on strong Q1 numbers amid surging growth in pet ownership
Health & Biotech
CannPal Animal Therapeutics signs agreement to register doggie drug DermaCann in South Africa
Health & Biotech
The ASX small caps looking to capitalise on post-COVID trends in animal health
Health & Biotech
Health Kick Podcast: Investors love Apiam’s diversified pet and livestock vet offering
Health & Biotech
Investors bullish on Apiam as ‘headwinds turn to tailwinds’
Health & Biotech
Health Kick Podcast: Cannpal has first mover advantage in the $67bn “hidden gem” animal health market
News
Shaver Shop and Apiam shrug off COVID-19 to record solid profits
Stockhead TV
StockTalk: Animal health is a $67bn hidden gem
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
Health & Biotech
Animal health: The $67bn hidden gem of the global healthcare market
Load More
